FDA set to authorize Pfizer-BioNTech COVID-19 vaccine for adolescents early next week: NYT

The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and BioNTech SE’s COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency’s plans.

This is a developing story. Check back for more details.